Posted by Michael Wonder on 27 Jun 2022
TLV receives a new assignment on precision medicine and ATMP
27 June 2022 - The Government has commissioned the Swedish Dental and Pharmaceutical Benefits Agency (TLV) to continue the work of developing methods for health economic evaluations of precision medicines and payment models for advanced therapy drugs that the authority has begun.
"We look forward to continuing this urgent work to create conditions for patients to have access to new innovative treatments and ensure that the costs are in good proportion to the size of the health benefit," says Agneta Karlsson, CEO of TLV.
